Immunogenicity and clinical features relating to BNT162b2 messenger RNA COVID-19 vaccine, Ad26.COV2.S and ChAdOx1 adenoviral vector COVID-19 vaccines: a systematic review of non-interventional studies

BACKGROUND: Vaccination against Coronavirus disease 2019 (COVID-19) is an important means of controlling the pandemic, however they are expected to stimulate immune responses when administered to confer immunity. In this review, we evaluated the clinical and laboratory features associated with BNT16...

Descripción completa

Detalles Bibliográficos
Autores principales: Iheanacho, Chinonyerem O., Eze, Uchenna I. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959558/
https://www.ncbi.nlm.nih.gov/pubmed/35368622
http://dx.doi.org/10.1186/s43094-022-00409-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959558/
https://www.ncbi.nlm.nih.gov/pubmed/35368622
http://dx.doi.org/10.1186/s43094-022-00409-5

Ejemplares similares